Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Peter Haverty
Introduction
Peter Haverty is a notable inventor based in San Francisco, California. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of colorectal cancers. His work is characterized by a focus on the FGFR2 gene, which plays a crucial role in cancer development.
Latest Patents
Peter Haverty holds a patent for "Methods and compositions for the diagnosis and treatment of cancer." This patent outlines innovative methods and compositions specifically designed for diagnosing and treating colorectal cancers associated with the amplification or overexpression of the FGFR2 gene. His research has the potential to improve treatment outcomes for patients suffering from this type of cancer.
Career Highlights
Haverty is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to cancer research.
Collaborations
Some of his notable coworkers include John Chant and Anthony S Guerrero. Their collaborative efforts have been instrumental in advancing research and developing new therapeutic strategies in oncology.
Conclusion
Peter Haverty's innovative work in cancer diagnosis and treatment exemplifies the impact of dedicated research in the medical field. His contributions continue to pave the way for advancements in cancer therapies, ultimately benefiting patients worldwide.